OncoSpherix’s CEO Will Give Keynote Presentation Entitled “Overcoming Past Challenges in Developing Safe and Effective Small Molecule Hypoxia Inducible Factor (HIF) Inhibitors for Treatment Of Aggressive Cancers” in San Francisco on Thursday, October 27

The Agile Falcon Drug Discovery Strategic Summit will be held at the Grand Hyatt at the San Francisco Airport on October 27-28, 2022. OncoSpherix’s CEO, Dr. Margaret Offermann, will be presenting a keynote address entitled “Overcoming Past Challenges in Developing Safe and Effective Small Molecule Hypoxia Inducible Factor (HIF) Inhibitors for Treatment Of Aggressive Cancers”. More information, including registration, is available at:  https://ddsswc.agilefalconsg.com